Cargando…
Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries
The COVID-19 pandemic highlighted significant gaps in equitable access to essential medical countermeasures such as vaccines. Manufacturing capacity for pandemic vaccines, therapeutics, and diagnostics is concentrated in too few countries. One of the major hurdles to equitable vaccine distribution w...
Autores principales: | Mukherjee, Sanjana, Kalra, Kanika, Phelan, Alexandra L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309624/ https://www.ncbi.nlm.nih.gov/pubmed/37384623 http://dx.doi.org/10.1371/journal.pgph.0002098 |
Ejemplares similares
-
Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities
por: Hayman, Benoit, et al.
Publicado: (2021) -
Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward
por: Kumraj, Ganesh, et al.
Publicado: (2022) -
Vaccine manufacturing capacity in low- and middle-income countries
por: Khan, Mohammed Imran, et al.
Publicado: (2021) -
Building the global vaccine manufacturing capacity needed to respond to pandemics
por: Sell, Tara Kirk, et al.
Publicado: (2021) -
Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism
por: Otu, Akaninyene, et al.
Publicado: (2021)